NCT03828747 A Study of Semorinemab in Patients With Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT03817684 Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects Status COMPLETED Phase PHASE2
NCT03790982 Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease Status UNKNOWN Phase PHASE2
NCT03740178 Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Status WITHDRAWN Phase PHASE1
NCT03712787 An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD) Status TERMINATED Phase PHASE2
NCT03672201 Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia Status ACTIVE_NOT_RECRUITING Phase NA
NCT03668405 A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD) Status TERMINATED Phase PHASE1
NCT03656042 To Evaluate the Efficacy and Safety/Tolerability Profiles of G-CSF in Subjects With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT03639987 A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities Status TERMINATED Phase PHASE2
NCT03625128 18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls Status COMPLETED Phase EARLY_PHASE1
NCT03594123 A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Status COMPLETED Phase PHASE3
NCT03531710 An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311 Status TERMINATED Phase PHASE2
NCT03503669 Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training Status COMPLETED Phase NA
NCT03491150 An Open-Label Crenezumab Study in Participants With Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT03456349 Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care Status COMPLETED Phase PHASE1
NCT03441516 Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia Status UNKNOWN Phase PHASE4
NCT03438604 A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS) Status COMPLETED Phase PHASE1
NCT03432195 A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations Status COMPLETED Phase PHASE1